Medtronic Overactive Bladder
Bladder control problems affect tens of millions of people every day. If you’re one of them, you should speak up.
Does this sound familiar?
- Urinating more than 8 times a day
- Avoiding social events
- Using pads to control leaks
- OAB is extremely common.
- 1 in 6 adults has OAB, or 43 million adults in the U.S.1,2
- 4.5 out of 10 adults don’t seek help for overactive bladder3
Ignoring OAB Poses Risks
People with undiagnosed OAB reported:3
- 54% loss of confidence
- 49% loss of self-esteem
- 45% loss of intimacy
You Are Not Alone – Find Relief for Bladder Control Problems
Learn more at www.controlleaks.com
What is Urinary Retention
Urinary retention is defined as the inability to completely or partially empty the bladder. You may be unable to start urination, or if you are able to start, you can’t fully empty your bladder.
Does This Sound Familiar?
- Difficulty starting to urinate
- Difficulty fully emptying the bladder
- Weak dribble or stream of urine
- Loss of small amounts of urine during the day
- Inability to feel when bladder is full
- Increased abdominal pressure
- Lack of urge to urinate
- Strained efforts to push urine out of the bladder
- Frequent urination
- Nocturia (waking up more than two times at night to urinate)
Why Is This Happening?
There are two general types of urinary retention: obstructive and non-obstructive. If there is an obstruction (for example, kidney stones), urine cannot flow freely through the urinary tract. Non-obstructive causes include a weak bladder muscle and nerve problems that interfere with signals between the brain and the bladder. If the nerves aren’t working properly, the brain may not get the message that the bladder is full.
Some of the most common causes of non-obstructive urinary retention are:
- Vaginal childbirth
- Pelvic injury or trauma
- Impaired muscle or nerve function due to medication or anesthesia
- Accidents that injure the brain or spinal cord
Obstructive retention may result from:
- Kidney or bladder stones
- Enlarged prostate (BPH) in men
Please note: InterStim™ is not indicated for Obstructive Retention
Treat Yourself to Less Worry
Urinary retention is a treatable condition. Don’t be afraid to speak up about your symptoms and how they affect your daily life. This will help your doctor find the right treatment for you.
Symptoms of urinary retention* include:
- Can’t tell if your bladder is full
- Holding increasingly large amounts of urine
- Weak or dribbling stream
- Needing to use a catheter
* Medtronic Bladder Control Therapies do not treat obstructive urinary retention.
There are many ways to manage bladder control problems. Remember, if conservative treatments don’t deliver the results you need, you have more options.
Conservative treatments can help some people but may not work very well (or at all) for others. All of these are relatively simple behavioral changes that you may already be doing.
- Diet and exercise: Changes may include decreasing your caffeine intake and getting more exercise.
- Bladder retraining: Also called biofeedback, this involves delaying going to the bathroom and sticking to a strict schedule.
- Pelvic floor strengthening: This can be accomplished through Kegel exercises, which involve repeatedly contracting and relaxing the muscles of the pelvic floor.
When lifestyle changes fail to deliver the results you want, oral medications are the next step. These medications can help control symptoms but may cause other issues.
You have to remember to take these medications every day. Some side effects can be unpleasant, such as dry mouth, blurry vision, constipation, and hypertension.2 Other side effects are more serious. In fact, data suggests that one class of drugs for OAB (anticholinergics) may increase risk of dementia in elderly people.3 Even more important, these medications don’t always work. In one survey, 72% of people said they stopped taking their medication after just six months.4
If conservative treatments don’t deliver the results you want, you have more options.
Medtronic Bladder Control Therapy Delivered by The InterStim™ System
Evidence suggests that breakdowns in the bladder-brain communication pathway may be a root cause of OAB and non-obstructive urinary retention.1,2,3 That’s why conventional treatments may not produce the results you want – they don’t directly target this miscommunication. Unlike conventional treatments, the Medtronic InterStim systems gently stimulate the sacral nerves in the pelvic area that control the bladder.4,5 This may help restore* bladder-brain communication and reduce symptoms.
Complications can occur with the evaluation, including movement of the wire, technical problems with the device, and some temporary pain. Your doctor or nurse will provide you with the information regarding how to operate the test device and inform you of other precautions related to the evaluation and activity restrictions.
Get more control with the InterStim Systems6,7
- 3X greater improvements in OAB quality of life9
- 82% of people achieved success† at 5 years6
- Only therapy that lets you see if it works before you and your doctor decide
- More than 375,000 people worldwide have chosen the Medtronic InterStim systems for more control and long-lasting relief6,7
- Recharge-free and rechargeable options let you choose the right device for your lifestyle
- Try it during an evaluation
- Proven long-term relief5
Is InterStim Right for You?
You may be a good candidate for Medtronic Bladder Control Therapy delivered by the InterStim systems if:
- You have significant OAB symptoms or non-obstructive urinary retention
- You’ve tried lifestyle changes and oral medications
- These therapies haven’t given you the relief you want
Say yes to the test
Take back control with an evaluation for an InterStim system
Unlike other bladder control treatments, this therapy lets you try it first with an evaluation – like a test run, not a long-term commitment.
Here’s how it works:
- The simple test starts at your doctor’s office or an outpatient center.
- A lead (thin wire) is inserted in the upper part of your buttock.
- The lead attaches to a small external device worn discreetly under your clothes.
- Stop, start, or adjust the therapy settings, with an easy-to-use programmer that resembles a smartphone.
- Go about most of your regular activities for 3 to 14 days
- Track your symptoms to see if they improve
Complications can occur with the evaluation, including movement of the wire, technical problems with the device, and some temporary pain. Your doctor or nurse will show you how to use the system and inform you of any activity restrictions and other precautions related to the evaluation.
Get more personalized treatment options
After your test, talk to your doctor about the results. Together, you can choose a powerful and personalized solution for your long-term care. Your evaluation device can be replaced with an implantable device called a neurostimulator during a short, outpatient procedure.
Bladder control therapy has risks similar to any surgical procedure. The most common adverse events experienced during clinical studies include pain at implant sites, new pain, lead migration, infection, technical or device problems, adverse change in bowel or voiding function, and undesirable stimulation or sensations. Any of these may require additional surgery or cause return of symptoms. Discuss these potential risks and benefits with your doctor.
Medtronic’s proprietary SureScan™ MRI technology is what enables patients to get full-body‡ 1.5 and 3T MRI scans. It is the only sacral neuromodulation system with this SureScan technology. This means:
- Full-body‡ 1.5 and 3T scans
- No impedance checks required prior to MRI scans
- Scans allowed even if you have had out-of-range impedances
- MRI mode is easy to activate or deactivate on Medtronic’s smart programmer without clinician or Medtronic interaction
- Digital display for clear confirmation of MRI mode activation
Access the Medtronic InterStim MRI Brochure to learn about our MRI Center of Excellence and MRI testing lab and for information on how to activate MRI mode on your smart programmer.
Frequently Asked Questions
Why is this therapy different?
You can try it before you decide, and it’s reversible if you change your mind later. And unlike injections, it doesn’t require self catheterization or repeated treatment visits.
What can this therapy do for me?
It may significantly reduce symptoms in people who have frequent urges to urinate or related frequent leaks or are unable to fully empty their bladder.1
Will it cure my condition?
No. It can be effective, but it’s not a cure. If the neurostimulator is turned off or removed, symptoms can return.
What does the stimulation feel like?
Most people describe the stimulation sensation as a tingling, flutter, or vibration in the pelvic area. It should not be painful. Stimulation settings can be adjusted, and sensations will vary from person to person.
Can I have an MRI?
People with an InterStim™ system can have a full-body‡ MRI scan under certain conditions. Your doctor will determine whether you meet those conditions.
Will insurance cover the costs?
Medicare and many private insurance companies cover this therapy. Talk to your doctor to learn more about your insurance coverage.
Record your symptoms to help your doctor understand your condition.
Care Pathway for Bladder Control
Understand all of your treatment options for dealing with bladder control issues.
Starting the conversation can be hard. This guide can help you talk to your doctor.
Medtronic Bladder Control Therapies
Understand your options and decide if a Medtronic Bladder Control Therapy is right for you.
Patient Therapy Guide – iCon™ Programmer (.pdf)
A handy guide to living with Medtronic Bladder Control Therapy delivered by the InterStim system, and to using your hand-held Medtronic iCon programmer.
Patient Therapy Guide – Smart Programmer (.pdf)
A handy guide to living with Medtronic Bladder Control Therapy delivered by the InterStim system, and to using your Samsung Smart Programmer device.
2. US Census Bureau 2020. US adult and under-age-18 populations: 2020 census. https://www.census.gov/library/visualizations/interactive/adult-and-under-the-age-of-18-populations-2020-census.html. Accessed June 20, 2022.
3. Leede Research, “Views on OAB: A Study for the National Association of Continence.” December 16, 2015.
1. American Urological Association. Diagnosis and treatment of non-neurogenic overactive bladder (OAB) in adults: an AUA/SUFU guideline. www.auanet.org/guidelines/overactive-bladder-(oab)-guideline. Accessed August 5, 2020.
2. Haab F, Castro‐Diaz D. (2005), Persistence with antimuscarinic therapy in patients with overactive bladder. Int J Clin Prac, 59: 931-937.
3. Gray S, Anderson M, Dublin S et al. Cumulative use of strong anticholinergics and incident dementia. JAMA Intern Med. 2015;175(3):401-407.
4. Yeaw J, Benner J, Walt JG et al. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm. 2009:15(9): 724-736.
5. Siegel S, Noblett K, Mangel J, et al. Five year follow-up results of a prospective, multicenter study in overactive bladder subjects treated with sacral neuromodulation. 2018; 199(1), 229-236.
*Restored function defined as a 50% or greater reduction in dysfunctional voiding symptoms from baseline
†Numbers reflect completers analysis defined as patients with diary data at baseline and 12 months (n=220). Clinical success was 82% at 12 months using the modified completers analysis (subjects who either had a baseline and 12-month evaluation or withdrew early due to device-related reasons and are considered failures). Success defined as a 50% or greater reduction in your troublesome bladder symptoms.
‡Under certain conditions; see approved labeling for details. Patients with InterStim™ SureScan™ MRI Leads only.
1. Dasgupta R. Critchley HD, Dolan RJ, Fowler CJ. Changes in brain activity following sacral neuromodulation for urinary retention. J Urol. 2005; 174:2268-2272
2. Griffiths D, Derbyshire S, Stenger A, Resnick N. Brain control of normal and overactive bladder. J Urol. 2005; 174:1862-1867.
3. Griffiths D, Tadic SD. Bladder control, urgency, and urge incontinence: evidence from functional brain imaging. Neurourol Urodyn. 2008;27(6):466-474.
4. Kenefick NJ, Emmanuel A, Nicholls RJ. Effect of sacral nerve stimulation on autonomic nerve function. British Journal of Surgery. 2003;90:1256-1260.
5. Patton V, Wiklendt L, Arkwright JW, Lubowski DZ, Dinning PG. The effect of sacral nerve stimulation on distal colonic motility in patients with fecal incontinence. Br J Surg. 2013;100:959-968.
6. Siegel S, Noblett K, Mangel J, et al. Five-year follow-up results of a prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation. J Urol. 2018; 199(1), 229-236.
7. Medtronic InterStim Therapy Clinical Summary (2018).
8. Foster RT Sr, Anoia EJ, Webster GD, Amundsen CL. In patients undergoing neuromodulation for intractable urge incontinence a reduction in 24-hr pad weight after the initial test stimulation best predicts long-term patient satisfaction. Neurourol Urodyn. 2007; 26:213-217.
9. Siegel S, Noblett K, Mangel J, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim® Therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn. 2015; 34:224-230.
1. Foster RT Sr, Anoia EJ, Webster GD, Amundsen CL. In patients undergoing neuromodulation for intractable urge incontinence a reduction in 24-hr pad weight after the initial test stimulation best predicts long-term patient satisfaction. Neurourol Urodyn. 2007; 26:213-217.